Zenotech Laboratories logo

Zenotech Laboratories financials: balance sheet, profit and loss, cash flow

BSE: 532039Pharmaceuticals & BiotechnologySmall Cap

Zenotech Laboratories Limited · Face value ₹10 · Listed Oct 1996
Last close ₹38.51up ₹0.56 (1.48%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹37.95.

30 Oct: open ₹38.44, high ₹38.80, low ₹38.00

52-week range of traded prices to 30 Oct 2026
₹33.55Low, 30 Mar 2026₹54.14High, 31 Oct 2025
Market cap
₹235 Cr2,190th largest listed
P/E
Lossover the last 12 months
P/B
2.55
Dividend yield
Nonein the last 12 months
ROE
−4.5%
ROCE
−8.8%
Debt to equity
0.00
Volume, BSE
6,968

Zenotech Laboratories' financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the half year to Sep 2026 after them. It had no borrowings at 30 Sep 2026.

10 years at a glance

₹ crore, years to March.Zenotech Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
2.3−20Mar 1711−12Mar 1813−3.120Mar 19261119Mar 2022−1.221Mar 2137226Mar 2238120Mar 23378.30Mar 24395.60Mar 2540−1.10Mar 26
A loss in the year to Mar 2026, −₹1.07 CrA loss in 5 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
60.6%−881.5%−459.9%−70.6%−27.0%34.3%28.4%47.8%43.4%35.8%25.9%13.0%−881.5%−106.3%−24.0%41.6%−5.4%60.6%30.2%22.6%14.4%−2.7%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

The years either side of a change of basis do not compare. From the year to Mar 2021, the company's revenue for that year, ₹22 Cr, differs from its quarters added, ₹20 Cr. From the year to Mar 2022, the company's revenue for that year, ₹37 Cr, differs from its quarters added, ₹35 Cr. From the year to Mar 2024, the company's revenue for that year, ₹37 Cr, differs from its quarters added, ₹38 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue40
  2. Employee costs−16
  3. Other expenses−19
  4. Operating profit5.1
  5. Depreciation−7.1
  6. Other income+6.4
  7. One-off items−0.2
  8. Finance costs0.0
  9. Profit before tax4.2
  10. Tax−5.3
  11. Net profit−1.1

What the company owns

  • Plant, investments and other assets₹72 Cr
  • Cash and bank₹30 Cr
  • Receivables₹9 Cr

What pays for it: net worth and liabilities

  • Net worth₹95 Cr
  • Other liabilities₹12 Cr
  • Owed to suppliers₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Zenotech Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 AprSep 2026Twelve monthsFiled 28 Oct
Revenue from operations2.311.113.025.922.436.638.436.839.039.636.4
12.619.016.517.016.119.121.723.628.934.437.2
Materials and goods bought1.70.80.70.50.00.00.10.00.80.00.0
Employee costs3.05.15.05.86.57.17.99.512.415.517.8
Other expenses7.913.110.810.89.512.013.814.115.618.919.4
Operating profit before depreciation−10.4−7.9−3.58.96.417.516.613.210.15.1−0.8
Operating margin−459.9%−70.6%−27.0%34.3%28.4%47.8%43.4%35.8%25.9%13.0%−2.2%
Materials, % of revenue74.0%7.2%5.5%1.9%0.1%0.0%0.2%0.0%2.2%0.0%0.0%
Employee costs, % of revenue134.0%45.5%38.2%22.2%28.9%19.4%20.5%25.7%31.8%39.2%48.9%
Other expenses, % of revenue351.8%118.0%83.3%41.5%42.5%32.8%35.9%38.5%40.2%47.8%53.3%
Depreciation and amortisation3.93.94.24.86.57.07.27.17.07.17.3
Operating profit after depreciation−14.2−11.8−7.74.0−0.110.59.56.13.1−2.0−8.1
Other income0.12.44.71.30.40.65.25.15.66.46.0
Finance costs7.52.40.10.91.51.20.10.00.00.00.0
Profit before one-off items and tax−21.7−11.9−3.14.4−1.29.914.511.18.84.4−2.1
One-off items1.8–0.06.40.00.00.00.01.9−0.2−0.2
Profit before tax−19.9−11.9−3.110.8−1.29.914.511.110.74.2−2.4
––0.00.00.0−12.32.92.85.15.31.9
Net profit−19.9−11.9−3.110.8−1.222.211.68.35.6−1.1−4.3
Other comprehensive income––0.00.00.00.10.00.00.00.00.1
Total comprehensive income––−3.110.7−1.222.211.68.35.6−1.0−4.2
Net margin−881.5%−106.3%−24.0%41.6%−5.4%60.6%30.2%22.6%14.4%−2.7%−11.7%
Earlier years, Mar 2012 to Mar 2016
₹ croreMar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations2.23.02.84.12.1
7.023.819.824.1–
Materials and goods bought1.32.12.53.21.9
Employee costs1.15.36.33.3–
Other expenses4.616.311.017.7–
Operating profit before depreciation−4.8−20.7−17.0−20.1–
Operating margin−220.9%−680.3%−616.8%−491.8%–
Materials, % of revenue60.9%70.5%90.8%78.3%–
Employee costs, % of revenue50.6%173.7%227.0%80.3%–
Other expenses, % of revenue209.3%536.2%399.0%433.1%–
Depreciation and amortisation3.53.53.64.1–
Operating profit after depreciation−8.3−24.2−20.6−24.1–
Other income0.10.22.40.30.4
Finance costs0.51.54.76.77.5
Profit before one-off items and tax−8.7−25.5−22.9−30.4−19.1
One-off items−1.6––––
Profit before tax−10.3−25.5−22.9−30.4−19.1
Net profit−10.3−25.5−22.9−30.4−19.1
Net margin−469.9%−838.4%−829.3%−746.0%−927.6%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 AprSep 2026Half yearFiled 28 Oct
395048718291969592
Share capital616161616161616161
Reserves−22−11−13102130353431
201921600000
453515161714131215
0022822243
Total assets85868694101106111111110
658078878580757074
196771626364136
Net debt718184−11−20−27−30−29
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 AprSep 2026Half year
5.717.720.711.89.510.23.4
5.918.721.912.911.49.64.4
−0.60.80.5−4.4−4.8−0.15.5
Receivables−1.9−0.10.60.1−4.2−1.36.9
Inventories0.00.00.1−0.80.80.0−1.6
Payables−2.40.21.4−0.7−1.01.30.9
Other working capital3.70.7−1.6−3.0−0.5−0.1−0.8
Tax paid−0.1−1.0−1.2−1.1−1.90.6−1.0
Capital spending4.91.96.24.23.98.35.9
Free cash flow0.815.714.47.65.61.9−2.5
−4.8−1.8−5.8−21.215.3−6.5−5.1
0.5−15.9−6.10.00.00.00.0
Dividends paid0.00.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.00.0
Net change in cash1.40.08.7−9.324.73.7−1.7
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 Apr
Earnings per share−₹5.77−₹2.24−₹0.51₹1.77−₹0.20₹3.63₹1.90₹1.36₹0.92−₹0.18
Diluted earnings per share−₹5.77−₹2.24−₹0.51₹1.77−₹0.20₹3.63₹1.90₹1.36–−₹0.18
Book value per share––₹6.37₹8.13₹7.93₹11.57₹13.48₹14.84₹15.75₹15.59
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)12824813090214307287361317209

Ratios

Standalone, years to March.Zenotech Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 Apr
Revenue growth9.4%394.4%16.9%99.1%––4.9%–6.0%1.5%
Operating profit growth––––––−4.7%–−23.1%−49.2%
Net profit growth––––––−47.8%−28.3%−32.5%–
Earnings per share growth––––––−47.7%−28.4%−32.4%–
––−8.0%24.3%−2.5%37.3%15.2%9.6%6.0%−1.1%
–––32.4 pts−26.8 pts39.7 pts−22.1 pts−5.5 pts−3.6 pts−7.1 pts
From the net margin–––22.0 pts−27.5 pts30.2 pts−18.7 pts−3.8 pts−3.5 pts−7.1 pts
From asset turnover–––13.6 pts0.4 pts15.3 pts−0.6 pts−1.1 pts0.1 pts0.0 pts
From borrowing–––−3.2 pts0.2 pts−5.8 pts−2.8 pts−0.6 pts−0.2 pts0.0 pts
Return on capital employed––−13.1%5.9%−0.1%13.7%11.5%6.7%3.3%−2.1%
Cash conversion–––––79.7%178.4%142.4%168.4%–
Interest cover–––4.5–8.684.3–––
Debt to equity––0.520.380.430.080.000.000.000.00
Receivable days––6626623932327081
Inventory days––2976870220,1750–0–
Payable days––2,0943,33021,7866,85,60320,872–798–
Cash conversion cycle, days––−1,730−3,235−21,022−6,65,389−20,841–−728–
Working capital days––−537−172−164−106−109−70−31−13
Asset turnover––0.150.300.260.410.390.360.360.36
Assets per rupee of net worth––2.171.921.751.511.281.201.161.16
Sales per rupee of plant––0.300.530.300.520.590.560.640.64
Capital spending to depreciation––––0.760.280.870.600.561.17
Plant being built, % of plant in use––39.3%59.7%2.9%0.4%7.6%3.0%5.9%5.8%
Interest cover is left blank for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth and operating profit growth are left blank for the years to Mar 2021, Mar 2022 and Mar 2024: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−1.0%
Cash from operations against operating profit
198.7%
Measure10 years5 years3 years
Return on equity, average–13.4%4.8%
Return on capital employed, average–6.6%2.6%
Operating margin, average−32.9%33.2%24.9%
Net margin, average−85.1%25.0%11.4%
Asset turnover, average–0.370.36
Debt to equity, average–0.020.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations69.831.510.2
Cash from investing−20.0−12.4−6.5
Cash from financing−22.00.00.0
Capital spending24.616.48.3
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid20.70.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––576665
Altman Z-scorePublished threshold 1.811.001.653.398.6810.4115.0414.129.05
Beneish M-scorePublished threshold −1.78––−1.97−0.89−2.91−2.72−1.52−3.01
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––−2.507.06−3.3417.03−17.61−4.31
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––1.351.191.642.45
Receivables growth less revenue growthOur threshold 0 percentage points–−120.33118.26−59.62−20.281.92123.3816.24
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−54.2259.4094.81−5,527.27–––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−1.41−7.18−0.142.161.60−1.420.01
Assets under construction, years of additionsOur threshold 2 years of additions–2.780.070.083.020.271.590.42
Effective tax ratePublished threshold 17.16 per cent–0.00–−123.9720.1125.4147.50125.59
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––−134.1111.9115.7929.37111.77
A threshold marked as ours has no published figure; it is the line we read the check against.